SLU-PP-332
A small-molecule ERR receptor agonist studied for driving mitochondrial biogenesis and endurance-related gene expression.
Research status: Early preclinical stage.
This page is a research-orientation summary, not a dosing guide. For anything beyond general background, read the primary literature or talk to a qualified clinician — specifics like amount, frequency, or administration aren't something we publish here.
Related in Small Molecule
- More coming soon.